As both KLK3 and KLK2 genes are regulated by AR signalling, it is reasonable to theorize that the 11B6 antibody could be used to image AR signalling in prostate cancer in a similar fashion to that reported with 5A10 [18]. This evidence concerns the gene AR and Familial prostate cancer.